John W. Matthei
Ufficiale delle Risorse Umane presso ATHENEXPAR
Profilo
John W.
Matthei is currently the Vice President-Human Resources at Athenex, Inc. He previously worked as the Executive Vice President-Human Resources at Stericycle, Inc. from 2004 to 2009.
He also held Vice President positions at Pfingsten Partners LLC and Sagent Pharmaceuticals, Inc. Mr. Matthei received his undergraduate degree from Loyola University of Chicago.
Posizioni attive di John W. Matthei
| Società | Posizione | Inizio |
|---|---|---|
| ATHENEXPAR | Ufficiale delle Risorse Umane | 01/09/2017 |
Precedenti posizioni note di John W. Matthei
| Società | Posizione | Fine |
|---|---|---|
| STERICYCLE, INC. | Ufficiale delle Risorse Umane | 01/01/2009 |
| SAGENT PHARMACEUTICALS INC | Public Communications Contact | - |
Pfingsten Partners LLC
 Pfingsten Partners LLC Investment ManagersFinance Pfingsten Partners LLC (Pfingsten Partners) is a private equity firm founded in 1989 by Thomas Steven Bagley. The firm is headquartered in Chicago, Illinois. | Investitore di Private Equity | - |
Formazione di John W. Matthei
| Loyola University of Chicago | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| STERICYCLE, INC. | Industrial Services |
| Aziende private | 3 |
|---|---|
Pfingsten Partners LLC
Pfingsten Partners LLC Investment ManagersFinance Pfingsten Partners LLC (Pfingsten Partners) is a private equity firm founded in 1989 by Thomas Steven Bagley. The firm is headquartered in Chicago, Illinois. | Finance |
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
Sagent Pharmaceuticals, Inc.
 Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
- Borsa valori
- Insiders
- John W. Matthei
